During the past decade, New Horizons Clinical Research conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 30 clinical trials were completed, i.e. on average, 81.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Horizons Clinical Research" #1 sponsor was "Pfizer" with 14 trials, followed by "Sunovion" with 4 trials sponsored, "Selecta Biosciences, Inc." with 3 trials sponsored, "Amphastar Pharmaceuticals, Inc." with 2 trials sponsored and "BioDelivery Sciences International" with 2 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Horizons Clinical Research" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "New Horizons Clinical Research" are "Asthma" (7 trials), "Chronic Obstructive Pulmonary Disease" (5 trials), "Osteoarthritis, Knee" (5 trials), "COPD" (4 trials) and "Low Back Pain" (4 trials). Many other conditions were trialed in "New Horizons Clinical Research" in a lesser frequency.

Most popular intervention types in "New Horizons Clinical Research" are "Drug" (57 trials), "Biological" (15 trials), "Other" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "placebo" (5 trials), "0.15% azelastine hydrochloride" (2 trials), "Linaclotide" (2 trials) and "Matching placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "New Horizons Clinical Research" are 69 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "New Horizons Clinical Research". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in New Horizons Clinical Research, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in New Horizons Clinical Research, 0 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".